Reports from Catholic University of Louvain (UCLouvain) Advance Knowledge in Lung Cancer (Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma)

Presse/Médias: Commentaire d'expert

période	23 nov. 2022

Couverture médiatique

titre	Reports from Catholic University of Louvain (UCLouvain) Advance Knowledge in Lung Cancer (Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma)
Media name / outlet	Cancer Daily
Pays/Territoire	États-Unis
la date	23/11/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66XR-PYK1-JBSP-10DM-00000-00
Personnes	Michael Dupont